Accéder au contenu
Merck

Anticoagulant effect of sodium dehydroacetate (DHA-S) in rats.

Journal of applied toxicology : JAT (2007-10-18)
Yuka Sakaguchi, Sachiko Suga, Keiyu Oshida, Keiko Miyamoto-Kuramitsu, Kohei Ueda, Yohei Miyamoto
RÉSUMÉ

Sodium dehydroacetate (DHA-S) is used as a food additive, preservative and antimicrobial agent. Repeated oral administration of DHA-S in rats induced severe hemorrhage in multiple organs and prolongation of blood coagulation factors. To determine the mechanism of hemorrhage, the protective effect of vitamin K (VK) was investigated. Increased VK-dependent blood coagulation parameters, a prolonged prothrombin time (PT) and an activated partial thromboplastin time (APTT) were observed in rats when DHA-S alone was administered, while only a slight change was observed in animals that received a single injection of vitamin K2 following the DHA-S dosing. These results suggest that DHA-S-induced hemorrhage is caused by a deficiency of vitamin K. In addition, the inhibitory effect of DHA-S on vitamin K1 epoxide reductase (VKOR) activity was measured with an in vitro system using liver microsomes of normal male rats. DHA-S concentration-dependently inhibited VKOR activity similar to warfarin, but the inhibitory concentration was high. Therefore, it was concluded that the DHA-S-induced hemorrhage was caused by a depletion of blood VK, associated with any factors including VKOR inhibition.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Dehydroacetic acid, ≥98.0% (T)